News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Recro Pharma (REPH) Announces Full Exercise Of Underwriters' Option To Purchase Additional Shares


3/11/2014 9:24:18 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

MALVERN, Pa., March 11, 2014 (GLOBE NEWSWIRE) -- Recro Pharma, Inc. (Nasdaq:REPH), a clinical stage specialty pharmaceutical company developing non-opioid therapeutics for the treatment of pain, today announced the full exercise of the over-allotment option granted to the underwriters to purchase an additional 562,500 shares of common stock at a public offering price of $8.00 per share, in connection with the company's recently announced initial public offering of 3,750,000 common shares. The full exercise of the option brings total gross proceeds from the offering to $34,500,000, before deducting underwriting discounts and commissions and other offering expenses payable by the company.

Help employers find you! Check out all the jobs and post your resume.

Read at GlobeNewswire


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES